Bunkerhill ECG-EF vs CVI42
AI Verdict
Choose Bunkerhill ECG-EF if…
Choose Bunkerhill ECG-EF if your primary goal is the rapid, non-invasive, and early identification of patients at risk for heart failure from routine 12-lead electrocardiograms. This tool is ideal for integrating into automated clinical workflows within primary care, emergency medicine, or large health systems to efficiently screen a broad patient population for reduced left ventricular ejection fraction.
View Bunkerhill ECG-EF →Choose CVI42 if…
Choose CVI42 if your clinical practice requires comprehensive and advanced analysis of cardiac and vascular imaging data from CT and MRI scans. This platform is best suited for specialized cardiology and radiology departments needing detailed insights into coronary plaque, advanced CMR automation, and 3D visualization for precise diagnosis, treatment planning, and complex case management.
View CVI42 →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Bunkerhill ECG-EF | CVI42 |
|---|---|---|
| Pricing | Contact sales for pricing details. | Starts at $5,000 per license. |
| Deployment | Cloud-native platform (Carebricks) that integrates with existing health system infrastructure like EHRs. | On-premise (standalone workstation or client/server) |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Bunkerhill ECG-EFBunkerhill ECG-EF (Tool A) focuses on analyzing routine 12-lead ECG data and integrates seamlessly with EHRs, suggesting a low barrier to entry and ease of use within existing, common clinical workflows. CVI42 (Tool B), while offering comprehensive imaging analysis, is an on-premise solution for advanced CT and MRI, which typically implies a more specialized user base and potentially higher IT overhead for deployment and maintenance.
Clinical Value
TieBoth tools offer significant clinical value in different aspects of cardiac care. Bunkerhill ECG-EF (Tool A) provides early identification of patients at risk for heart failure by detecting reduced LVEF from routine ECGs, which is valuable for broad screening and early intervention. CVI42 (Tool B) offers in-depth, comprehensive analysis for advanced cardiac and vascular imaging, including FDA-cleared coronary plaque analysis, which is critical for detailed diagnosis, risk stratification, and treatment planning in complex cases.
Pricing & Value
CVI42While both tools require direct contact for pricing, CVI42 (Tool B) provides more transparency by detailing a flexible subscription model that scales across service lines and mentions additional licenses for specific modules. This offers potential customers a clearer understanding of the cost structure and scalability compared to Bunkerhill ECG-EF (Tool A), which only states 'contact for pricing'.
Enterprise Readiness
Bunkerhill ECG-EFBunkerhill ECG-EF (Tool A) explicitly states HIPAA compliance, BAA availability, and FDA clearance, along with seamless EHR integration, which are crucial for enterprise adoption. CVI42 (Tool B) does not disclose BAA or HIPAA compliance in the provided facts, and its FDA clearance is specifically for the 'Plaque' module rather than the entire platform, making Tool A appear more comprehensively enterprise-ready based on disclosed information.
Innovation
TieBoth tools demonstrate significant innovation in their respective fields. Bunkerhill ECG-EF (Tool A) innovates by extracting complex cardiac functional information (LVEF) from a simple, widely available ECG, enabling broad early detection of heart failure risk. CVI42 (Tool B) showcases innovation in automating and enhancing the analysis of complex, high-resolution imaging data, providing detailed insights for advanced diagnostics and treatment planning, including AI-automated coronary plaque analysis.
Support & Docs
CVI42CVI42 (Tool B) offers a comprehensive suite of support resources, including a dedicated Technical Support page with access to documentation for various versions, HL7 Conformance Statements, System Requirements, a Customer Portal, archived tutorials, and workshops. Bunkerhill ECG-EF (Tool A) does not have readily available public information regarding dedicated support portals or extensive documentation beyond general contact options.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Bunkerhill ECG-EF | CVI42 |
|---|---|---|
| Tool Name | Bunkerhill ECG-EF | CVI42 |
| Company | BunkerHill Health | CIRCLE CARDIOVASCULAR IMAGING |
| Description | Bunkerhill ECG-EF is an FDA-cleared artificial intelligence algorithm by BunkerHill Health that detects reduced left ventricular ejection fraction (LVEF u2264 40%) from routine 12-lead electrocardiograms (ECGs), aiding in the early identification of patients at risk for heart failure. | CVI42 is an AI-enabled software platform by Circle Cardiovascular Imaging for comprehensive cardiac and vascular imaging analysis, enhancing diagnosis, planning, and patient care with advanced CT and MRI tools. |
| Primary Function | Detects reduced Left Ventricular Ejection Fraction (LVEF u2264 40%) from 12-lead ECGs. | Comprehensive cardiac and vascular imaging analysis using CT and MRI. |
| Key Data Input | Routine 12-lead ECG data | Cardiac and vascular CT and MRI data |
| Specialties | Cardiology, Emergency Medicine, Internal Medicine | Cardiology, Cardiothoracic Surgery, Radiology |
Videos
Demos, reviews, and walkthroughs featuring Bunkerhill ECG-EF and CVI42.